In cancer, decreased MnSOD expression is linked to mechanisms such as epigenetic silencing, promoter methylation, mutations, and loss of heterozygosity, as seen in cancers like brain, breast, colorectal, and pancreatic [17]. Here, SOD2 is linked to cancer.